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Malignant histiocytosis (MH) is a progressive systemic neoplastic proliferation
of morphologically atypical histiocytes, well characterised in humans and dogs
but only recently identified in the cat. In all species, liver, lung, lymph nodes,
spleen and bone marrow are infiltrated by atypical histiocytes, and the disease
is rapidly fatal. The purpose of this study was to describe the clinical, histolo-
gical, immunohistochemical and ultrastructural findings of MH in a cat, together
with the diagnostic work-up and a list of differential diagnoses. Clinical evalu-
ation included a complete blood-cell count, serum biochemistry, urinalysis, se-
rology and ultrasound examination. The cat had clinical signs of depression,
thinness, dehydration, pale mucous membranes and tachycardia. Abdominal
ultrasonography revealed generalised splenomegaly and hepatomegaly. Ne-
croscopy showed whitish nodules, randomly scattered throughout the paren-
chyma in the spleen and liver. The periportal lymph nodes were greatly en-
larged and the cut surface was uniformly greyish-white and translucent. Histo-
logical examination revealed pleomorphic proliferation of large round tumour
cells, with numerous phagocytic vacuoles containing erytrocytes, leukocytes
and haemosiderin. By immunohistochemistry, positivity for lysozyme and
a1-antitrypsin and a scattered positivity for Mac 387 were observed. Ultrastructur-
al features of tumour cells included cytoplasmic lipid droplets, lysosomes and
phagolysosomes. MH in the cat needs to be differentiated from diffuse granu-
lomatous disease, non-Hodgkin’s lymphoma and Hodgkin’s-like disease. The
morphological features of the tumour cells, combined with immunohistochem-
ical and ultrastructural observation, are consistent with a diagnosis of MH in
the cat. (Folia Morphol 2008; 67: 299–303)
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INTRODUCTION
Malignant histiocytosis (MH) is a progressive sys-
temic neoplastic proliferation of morphologically
atypical histiocytes [15, 17]. The disease, originally
described in man as histiocytic medullary reticulosis
and later termed malignant histiocytosis, is clinical-
ly characterised by fever, malaise, weight loss, gene-
ralised lymphadenopathy and hepatosplenomegaly
[21, 22]. Anaemia is commonly found, and it is some-
times associated with leukopenia and thrombocy-
topenia. Histologically, the neoplastic histiocytes are
found as a diffuse, non-cohesive proliferation in the
lymph nodal medullary zones, splenic red pulp and
hepatic sinusoids, lung, and bone marrow [21, 22].
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Most cases of MH have been reported in man
[21, 22] and in dogs, particularly in the Bernese
Mountain breed [10, 13, 17]. MH is uncommon in
cats, and its documentation is limited to a few case
reports [2, 3, 5, 6, 8, 19, 20]. Here we describe the
clinical, histopathological, immunohistochemical
and ultrastructural features of malignant histiocy-
tosis in a cat, together with the diagnostic work-up
and a list of differential diagnoses.
CASE REPORT
A ten-year-old spayed female domestic shorthair
cat weighing 4 kg was examined for an 8-month
history of listlessness, inappetence, progressive
weight loss, marked lethargy, anorexia and vomit-
ing. Physical examination revealed depression, thin-
ness, approximately 8% dehydration, pale mucous
membranes and tachycardia (205 beats/min). The
rectal temperature was 38.6°C. A normocytic hypo-
chromic regenerative anaemia (RBC: 2.6 ¥ 1012/L,
reference interval 5.5–8.5 ¥ 1012/L; haematocrit:
13%, reference interval 30–45%; MCHC: 30%, refer-
ence interval 31–35%; MCV: 49 m3, reference inter-
val 40–55 m3; reticulocytes: 4%, reference interval
0.2–16%) was revealed by haematological exami-
nation. A leukogram and thrombogram were nor-
mal. Serum biochemical abnormalities included mild
hyperglycaemia (164 mg/dL; reference interval 70–
–110 mg/dL) and an increase in activity of alanine
aminotransferase (60 UI/L; normal value < 50 UI/L).
Urinalysis was normal. Serum tests with an ELISA
assay (SNAP combo plus, IDEXX, Laboratories, Italia)
for feline immunodeficiency virus, feline infectious
peritonitis virus antibodies and feline leukaemia vi-
rus antigen were negative. Direct Coomb’s test was
negative and numerous blood smears failed to re-
veal Mycoplasma haemofelis, even if the absence of
these organisms on a blood smear does not exclude
the possibility of infection. In fact, this method not
only lacks sensitivity but is also not adequately spe-
cific because the morphology of M. haemofelis can
easily be confused with other micro-organisms such
as rickettsia. Abdominal ultrasonography revealed
splenomegaly and hepatomegaly with hyperechoge-
nicity and moderate hepatic venous congestion.
Response to supportive treatment was poor and the
cat died one week later.
At post-mortem examination all cavities con-
tained a yellowish-green serosanguineous fluid. Sig-
nificant gross lesions were evident in the spleen,
which was enlarged, firm and contained multiple
whitish nodules from 0.5 to 4.0 mm in diameter,
randomly scattered throughout the parenchyma
(Fig. 1). Similar nodules were observed in the liver.
The periportal lymph nodes were greatly enlarged
and the cut surface was uniformly greyish-white and
translucent.
Tissue samples of all organs were fixed in 10%
neutral buffered formalin, embedded in paraffin wax
and stained with haematoxylin and eosin, Periodic
Acid-Schiff (PAS), Gomori’s methenamine silver and
the Gram and Ziehl-Nielsen techniques to reveal the
presence of pathogens.
Immunohistochemical staining was performed
on sections from the collected samples using a com-
mercial kit (Dako LSAB K680, Burlingame, CA, USA).
The paraffin sections were dewaxed, rehydrated and
blocked for endogenous peroxidase activity by treat-
ment for 20 min with 0.3% H2O2 and in absolute
methanol for 30 min. The sections were incubated
overnight in a humidified chamber at 4°C with well-
established monoclonal antibodies against Myeloid/
Histiocyte antigen (clone Mac 387), CD 79 — B cell
(clone HM 57), CD 3 — T cell, lysozyme (Murami-
dase), a1-antitrypsin and anti-vimentin (clone V9),
obtained from DAKO (Burlingame, CA, USA). All the
antibodies were well characterised and regularly
used in the veterinary laboratories. Briefly, the pri-
mary antibodies were all diluted 1 in 300 and ap-
plied overnight at 4°C, and the reaction was devel-
oped with 3,3-diaminobenzidine tetrahydrochloride
(Sigma, St. Louis, MO, USA) and counterstained with
haematoxylin. Controls for staining specificity were
omission of the primary antibody, its replacement
with non-immune sera or use of an irrelevant anti-
body. The intensity of labelling in each specimen was
scored as: 0, absent; +, weak; ++, moderate; +++,
strong.
For electron transmission microscopy (TEM) the
samples were fixed in 2.5% glutaraldehyde, post-
Figure 1. Spleen: multiple, whitish nodules, randomly scattered
throughout the parenchyma.
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fixed in osmium tetroxide and embedded in low-
viscosity Spurr resin. Ultrathin sections were cut,
counterstained with 0.5% uranyl acetate and lead
citrate and examined with a Zeiss 902 electron trans-
mission microscope.
Significant histological lesions were observed in
sections of the spleen, liver, lungs, periportal and
mediastinal lymph nodes. Histological examination
of the spleen revealed foci of pleomorphic giant his-
tiocyte-like cells that varied widely in size (from
20 to 35 mm) and had an abundant fine granular
structure in a foamy cytoplasm and fairly well-de-
lineated cell margins. The cells had centrally-placed
round nuclei of variable size or eccentrically-placed
indented or folded nuclei, with a regular chromatin
pattern and one or two generally large indistinct
nucleoli. Individual cells were atypical and showed
anisocytosis and anisokaryosis. There were much mi-
tosis, and bizarre mitotic figures were readily seen
(Fig. 2). Among these cells multinucleated giant cells
were frequently present. Both multinucleated and
mononucleated tumour cells showed phagocytosis
of the erythrocytes and leucocytes (Fig. 2).
Bone marrow was cytologically evaluated. The
cellularity was in the range of normal to slightly in-
creased, with hyperplasia of the erythroid popula-
tion (myeloid/erythroid ratio = 0.36). Atypical histi-
ocytic cells (50%) as seen in the splenic mass were
present in the bone marrow, and these were char-
acterised by large cytoplasmic basophilia and prom-
inent and multiple nucleoli. Many histiocytic cells
were phagocytising myeloid and erythroid cells and
platelets. Rare multinucleate giant cells were
present. Furthermore we observed immature mye-
loid cells (4%), mature myeloid cells (8%), imma-
ture erythroid cells (10%), mature erythroid cells
(20%), lymphocytes (5%) and megakaryocytes (3%).
Neoplastic histiocytes, morphologically similar to
those seen in the spleen, were also observed in the
liver, in the lungs and in the periportal and medias-
tinal lymph nodes.
PAS, Gomori’s methenamine silver and the Gram
and Ziehl-Nielsen stains did not show the presence
of bacteria or fungi in the cytoplasm of the atypical
cells.
By immunohistochemistry most tumour cells
were positive for lysozyme, although the intensity
of staining was greatly variable (Fig. 3); a1-antit-
rypsin immunoreactivity was less frequent and less
intensely stained compared to lysozyme stain, while
Mac 387 immunoreactivity was variable and only
a few cells were strongly positive. Only a few neo-
plastic cells were positive for vimentin. No neoplastic
cells were positive for CD 3 and CD 79 (the immuno-
histochemistry results are summarised in Table 1).
Ultrastructurally, the neoplastic cells were non-
cohesive and showed ovoid or pleomorphic multi-
segmented nuclei with dispersed chromatin. Nucle-
oli were usually large and sometimes multiple. Lipid
droplets and numerous primary and secondary ly-
sosomes were seen in many cells (Fig. 4). The ultra-
structural features of the tumour cells were consis-
tent with those of histiocytic cells [4, 7].
DISCUSSION
A definitive diagnosis of MH has to be made his-
tologically on the basis of the distribution of the
neoplastic cells in the body and on the immuno-
Figure 2. Spleen: pleomorphic malignant histiocytes mixed with
some lymphocytes; HE ¥250. Insert: atypical mitosis in neoplas-
tic cells which contain phagocytised leucocytes. HE ¥500.
Figure 3. Lysozyme immunoreactivity in tumour cells (arrows).
Streptavidin-Biotin-Method ¥500.
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histochemical and ultrastructural findings. Malig-
nant histiocytosis in the cat needs to be differenti-
ated from diffuse granulomatous disease, non-
Hodgkin’s lymphoma and Hodgkin’s-like disease.
The morphological appearance of the tumour
cells observed in this study was consistent with
a histiocytic lineage. The presence of large pleomor-
phic mononuclear cells and many multinucleated
giant cells with abundant, often vacuolated, cyto-
plasm, as well as the observation that these cells
also showed phagocytic activity, suggest a histio-
cytic lineage.
The histiocytic lineage of the tumour cells was
inferred from the immunohistochemical demonstra-
tion of lysozyme and a1-antitrypsin and from the
absence of immunoreactivity for CD 3 and CD 79,
markers of T and B cells respectively. In humans and
dogs lysozyme and a1-antitrypsin are both well char-
acterised immunohistochemical markers of mono-
nuclear phagocyte differentiation [1, 11, 14], and
lysozyme has been demonstrated in almost all re-
ported cases of human, canine and feline MH  [9, 12,
13, 16, 22, 23].
The lack of positivity for Mac 387 and for vimen-
tin could be explained by a high degree of anapla-
sia achieved by neoplastic cells in the case described.
A further condition that should be considered
in the list of differential diagnoses is diffuse gran-
ulomatous disease. This disorder is most often
a consequence of viral and bacterial infections (in-
cluding Mycobacterium tuberculosis and atypical
mycobacteria) and is characterised by the pres-
ence of phagocytic histiocytes in the bone mar-
row, lymph nodes, liver and spleen. In MH the neo-
plastic histiocytic cells show marked atypia, where-
as in the granulomatous disease the predominant
cell type is a mature and actively phagocytic mac-
rophage [1].
Non-Hodgkin’s lymphoma, particularly of the
T-lineage, may be misdiagnosed as MH when a his-
tiocytic proliferation is associated with the condi-
tion, or if the neoplastic T cells exhibit haemo-
phagocytosis [1]. Immunohistochemistry for CD 3 and
Mac 387 is usually helpful in diagnosis of T-cell lym-
phoma. In the differential diagnosis we also consid-
ered Hodgkin’s lymphoma (lymphocytes depletion
subtype), because many Reed Sternberg-like large
cells with the morphological hallmarks of polyploidy
(double or multi-lobed nuclei) were observed. One
case of Hodgkin’s-like disease with the morpholo-
gical hallmarks of Reed-Sternberg cells has been re-
ported in cat [18], but unlike the Reed-Sternberg
cells the neoplastic histiocytes in the present case
did not show eosinophilic nucleoli and displayed
a propensity for phagocytosis.
Furthermore, the electron microscopy findings
confirmed the histiocytic lineage of the tumour cells.
Cytoplasmic vacuoles, lipid droplets, and numerous
lysosomes are well recognised features of the mac-
rophages and have already been described by oth-
ers in human MH [5, 16].
In conclusion, the morphological features of the
tumour cells with the prevalence of cytologically bi-
zarre, highly phagocytic, multinucleated giant cells,
taken together with the immunohistochemical and
ultrastructural results, represent significant features
in enabling a diagnosis to be made of MH and in
differentiating malignant histiocytosis from other
conditions.
Table 1. The immunohistochemistry results
Antibodies Percent age of positive
neoplastic histiocytes
(intensity of labelling)
Lysozyme (muramidase) 90% (+++)
a1-antitrypsin 50% (++)
Myeloid/histiocyte antigen 40% (+)
(clone Mac 387)
Anti-vimentin (clone V9) 10% (+)
CD 3 — T cell Negative (0)
CD 79 — B cell (clone HM 57) Negative (0)
Figure 4. Neoplastic histiocyte with an expanse of cytoplasm,
large lysosomes and an erythrophagosome. Electron microscopy
(EM) ¥14,500.
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